Abnormal evoked potentials in autoimmune glial fibrillary acidic protein astrocytopathy

Fang, 2016, Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis, JAMA Neurol, 73, 1297, 10.1001/jamaneurol.2016.2549 Flanagan, 2017, Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients, Ann Neurol, 81, 298, 10.1002/ana.24881 Shu, 2018, Brain immunohistopathology in a patient with autoimmune glial fibrillary acidic protein astrocytopathy, Neuroimmunomodulation, 25, 1, 10.1159/000488879 Kunchok, 2019, Autoimmune glial fibrillary acidic protein astrocytopathy, Curr Opin Neurol, 32, 452, 10.1097/WCO.0000000000000676 Udupa, 2013, Central motor conduction time, Handb Clin Neurol, 116, 375, 10.1016/B978-0-444-53497-2.00031-0 Marra, 1990, The clinical significance of the bifid or “W” pattern reversal visual evoked potential, Clin Electroencephalogr, 21, 162, 10.1177/155005949002100312 Kimura, 2019, Cytokines and biological markers in autoimmune GFAP astrocytopathy: the potential role for pathogenesis and therapeutic implications, J Neuroimmunol, 334, 576999, 10.1016/j.jneuroim.2019.576999